20240325_SILO_Laporan Informasi dan Fakta Material_31619404_lamp1.pdf

As the result, a more seamless patient’s experience is created in every step, thus reducing average
patient’s waiting time by 27% in 4Q2023 compared to 1Q2023. To further improve the Company’s quality
of service, Siloam continued to develop its digital patient feedback system in FY2023 with more than
80% of complaints resolved within 2 hours.

Siloam’s investments in digital channels such as the MySiloam App and Website have shown significant
results as the number of website monthly traffic had increased from less than 200 thousand in FY2020 to
more than 12 million in FY2023. The MySiloam App was downloaded more than 2.5 million times with an
average Active Engagement Rate of 78% in FY2023. These digital channels contributed ~21% of total
Outpatients Visits in FY2023.

The afore-mentioned strategies together with Siloam’s excellent execution has led to the following
financial and operational results.

           Operational Results        FY2023    FY2022 % growth 4Q2023     4Q2022 % growth
        Operational Beds (beds)           3,987     3,784   5.4%     3,987    3,784    5.4%
        Inpatient Admissions            302,463   240,842  25.6%    79,272   67,995   16.6%
        Inpatient Days (days)           939,877   813,676  15.5%   242,912  226,059    7.5%
        Occupancy Rate (%)               65.2%     58.9%   10.7%    66.2%    65.2%     1.5%
        Outpatient Visits             3,949,341 3,210,291  23.0% 1,066,474  896,964   18.9%

         Financial Results (IDR mn)   FY2023    FY2022 % growth 4Q2023     4Q2022 % growth
        Net Revenue                   8,662,589 7,393,182  17.2% 2,289,456 2,010,029  13.9%
        EBITDA                        2,670,490 1,984,161  34.6%   719,889   589,319  22.2%
        EBITDA Margin (%)                30.8%     26.8%    14.9%      32.3%     29.3%      10.4%
        Net Profit                    1,247,044   710,381   75.5%    363,212    253,039     43.5%
        Net Profit Margin (%             14.4%      9.6%    49.8%      16.3%     12.6%      29.7%



Remarks from Siloam’s President Director:

Siloam’s President Director, Mr. Benny Haryanto, commented on the results: “I am delighted to announce
that in 2023, Siloam has achieved exceptional results and set new benchmarks for excellence within the
healthcare industry. Siloam has served over 4 million Outpatients in FY2023. Inpatient Admissions and
Inpatient Days each recorded at more than 302 thousand patients, more than 930 thousand days in
FY2023 and each grew 25.6%, 15.5%, compared with FY2022. Central to our success has been the
expansion of our extensive clinical programs, which have not only driven groundbreaking advancements
in clinical capabilities but have also significantly enhanced patient outcomes and experiences. My sincere
appreciation to our partners, stakeholders, and shareholders for their invaluable support and
collaboration throughout the year. Together, we have fostered a culture of innovation and excellence that
has propelled Siloam to new heights, and I am confident that our continued partnership will lead to even
greater success in the future.”
lain (radiasi, hormonal, sunti


For more information, please contact:

Wily Tjandera
Investor Relations Senior Officer
Siloam Hospitals Group
wily.tjandera@siloamhospitals.com
+628179000128

About Siloam Hospitals Group

PT Siloam International Hospitals Tbk (“Siloam Hospitals”) is a network of private hospitals in Indonesia committed
to providing high quality health services in Indonesia. Starting business in 1996, Siloam Hospitals currently manages
and operates 41 hospitals, consisting of 15 hospitals in the Greater Jakarta area and 26 hospitals spread across the
islands of Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara and Ambon. Siloam Hospitals Group also
operates 72 Siloam Clinics.

Siloam Hospitals' vision is to provide international quality healthcare and reach all levels of society on a national
scale based on Godly compassion which is the basis for Siloam Hospitals to respond to the dynamic social
transformation in Indonesia. Siloam Hospitals' mission is to be the trusted choice for world-class holistic healthcare,
health education and research.

Siloam Hospitals is the pioneer of Joint Commission International (JCI) accreditation for hospitals in Indonesia. JCI is
an international accreditation agency based in the United States that focuses on improving the quality of health
care and patient safety.

For more information about Siloam Hospitals, visit www.siloamhospitals.com.

Disclaimer: This Press Release is prepared by Siloam Hospitals and is distributed only to convey general information. This Press Release is not
intended for a particular group or purpose and does not constitute a recommendation regarding the shares of Siloam Hospitals. No guarantee is
given regarding the completeness or certainty of the information contained. All opinions and estimates included in this Press Release are our
opinions as of this date and are subject to change without notice. Siloam Hospitals is not responsible for any losses that may occur to any party
due to part or all of the contents of this Press Release, Siloam Hospitals and affiliated companies including their employees and agents are not
responsible for any mistakes, omissions, omissions or inaccuracies that can happen.

Predictive Statements: Some of the statements in this Press Release are or may be predictive in nature. These statements generally contain
words such as "will", "hopes", "anticipates" or the like. By their nature, predictive statements carry risks and uncertainties that may cause realities
that are different from what is explained in this Press Release. Factors that can cause different realities include but are not limited to: the
economic, social and political situation in Indonesia; the health industry situation in Indonesia; market situation; additional regulatory burdens
in Indonesia, including regulations relating to the environment and regulatory compliance costs; fluctuations in foreign exchange rates; interest
rate development, capital costs and capital availability; anticipated demand and supply prices related to our health services and related capital
expenditures and other investments; construction costs; availability of health services; competition from companies and other locations; changes
in customer demand; changes in operational costs, including employee salaries, wages and training, changes in public and government policies;
our ability to stay competitive; financial conditions, business strategies and plans and targets set by our management for future work;
procurement of future income; compliance with environmental and remediation regulations. If, among other things, one or more of the risks or
uncertainties mentioned above occur, the actual results may differ materially than predicted, anticipated or projected. In particular, but not
limited, capital costs can increase, projects can be postponed and anticipated increases in production, capacity or implementation may not all
occur. Although we believe that our management's expectations expressed in predictive statements are reasonable based on the information
we have at the moment, we cannot provide guarantees that these expectations can become reality. You should not depend on these statements
immediately. However, these statements apply only to the date they were stated, and we are not responsible for making updates or revisions,
even if new information, new events or anything is available.